Long-term Follow-up of Participants Dosed with an Investigational Gene Editing Therapy for Cardiovascular Disease

计划入组 116 人 · 首次发布于 2023 年 11 月 1 日

Gene Editing For Sickle Cell Disease

计划入组 25 人 · 首次发布于 2024 年 7 月 17 日

Gene Editing as a Therapeutic Approach for Rett Syndrome

计划入组 40 人 · 首次发布于 2023 年 2 月 23 日

AAV gene editing therapies

AAV gene editing therapies (Homology Medicines)

Gene editing therapies(Myeloid Therapeutics/Prime Medicine)

Taysha Gene Therapies

United States

Astellas Gene Therapies, Inc.

United States

BIONTECH CELL & GENE THERAPIES GMBH

Sweden

Bayer and CRISPR Therapeutics Form $300 Million Joint Venture to Advance Gene-Editing Therapies

Vertex Pharmaceuticals Partners with Enlaza Therapeutics in $45 Million Deal to Develop Autoimmune and Gene-Editing Therapies

NIH Grant Funds Gene-Editing Research for Rare Metabolic Disorders